NCT00003219View on ClinicalTrials.gov

Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1998

Primary Completion Date

May 31, 1998

Study Completion Date

May 31, 1998

Conditions
Breast Cancer
Interventions
DRUG

perillyl alcohol

Trial Locations (1)

53792

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00003219 - Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter